Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Mesylate”

628 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 628 results

Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Study completedNCT00784446
What this trial is testing

First-line Therapy of Stage IV Colorectal Cancer

Who this might be right for
Stage IV Colorectal Cancer
University of Cologne 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03516279
What this trial is testing

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveMinimal Residual Disease
ECOG-ACRIN Cancer Research Group 40
Testing effectiveness (Phase 2)Study completedNCT04193553
What this trial is testing

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Who this might be right for
Gastro Intestinal Stromal Tumour
Centre Leon Berard 77
Not applicableStudy completedNCT00049569
What this trial is testing

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
L1 Childhood Acute Lymphoblastic LeukemiaL2 Childhood Acute Lymphoblastic LeukemiaNon-T, Non-B Childhood Acute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 126
Not applicableStudy completedNCT00580281
What this trial is testing

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Who this might be right for
Gastric CancerLeukemiaChronic Myelogenous Leukemia
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00385203
What this trial is testing

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
AstraZeneca 35
Early research (Phase 1)Study completedNCT00613054
What this trial is testing

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 27
Early research (Phase 1)Study completedNCT00352677
What this trial is testing

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphocytic Leukemia
CytRx 100
Testing effectiveness (Phase 2)Study completedNCT01011075
What this trial is testing

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
New Mexico Cancer Research Alliance 34
Early research (Phase 1)Study completedNCT04903730
What this trial is testing

Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

Who this might be right for
Pulmonary Arterial Hypertension
Aerami Therapeutics 83
Testing effectiveness (Phase 2)Study completedNCT00154336
What this trial is testing

Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00045734
What this trial is testing

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Who this might be right for
Adult Grade I MeningiomaAdult Grade II MeningiomaAdult Grade III Meningioma+3 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT02495519
What this trial is testing

A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)

Who this might be right for
Fibromatosis
Yonsei University 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, School of Medicine, Zhejiang University 135
Testing effectiveness (Phase 2)UnknownNCT01541709
What this trial is testing

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT00866736
What this trial is testing

Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Kanto CML Study Group 65
Not applicableWithdrawnNCT01650467
What this trial is testing

Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Centre Hospitalier Universitaire de Nīmes
Testing effectiveness (Phase 2)Study completedNCT00417807
What this trial is testing

Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors

Who this might be right for
Refractory Desmoplastic Small Round Cell Tumors
Novartis Pharmaceuticals 9
Large-scale testing (Phase 3)Ended earlyNCT00751036
What this trial is testing

Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 94
Load More Results